110 related articles for article (PubMed ID: 10505097)
1. Transient cyclophosphamide treatment before intraportal readministration of an adenoviral vector can induce re-expression of the original gene construct in rat liver.
Kuriyama S; Tominaga K; Kikukawa M; Tsujimoto T; Nakatani T; Tsujinoue H; Okuda H; Nagao S; Mitoro A; Yoshiji H; Fukui H
Gene Ther; 1999 May; 6(5):749-57. PubMed ID: 10505097
[TBL] [Abstract][Full Text] [Related]
2. Repeated adenoviral administration into the biliary tract can induce repeated expression of the original gene construct in rat livers without immunosuppressive strategies.
Tominaga K; Kuriyama S; Yoshiji H; Deguchi A; Kita Y; Funakoshi F; Masaki T; Kurokohchi K; Uchida N; Tsujimoto T; Fukui H
Gut; 2004 Aug; 53(8):1167-73. PubMed ID: 15247187
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulation with FK506 around the time of intravenous re-administration of an adenoviral vector facilitates gene transfer into primed rat liver.
Kuriyama S; Tominaga K; Mitoro A; Tsujinoue H; Nakatani T; Yamazaki M; Nagao S; Toyokawa Y; Okamoto S; Fukui H
Int J Cancer; 2000 Mar; 85(6):839-44. PubMed ID: 10709105
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated gene transfer into rat livers: comparative study of retrograde intrabiliary and antegrade intraportal administration.
Kuriyama S; Yoshiji H; Nakai S; Deguchi A; Uchida N; Kimura Y; Inoue H; Kinekawa F; Ogawa M; Nonomura T; Masaki T; Kurokohchi K; Watanabe S
Oncol Rep; 2005 Jan; 13(1):69-74. PubMed ID: 15583804
[TBL] [Abstract][Full Text] [Related]
5. Intravenous readministration of an adenoviral vector performed long after the initial administration failed to induce re-expression of the original transgene in rats.
Tsujinoue H; Kuriyama S; Tominaga K; Okuda H; Nakatani T; Yoshiji H; Tsujimoto T; Akahane T; Asada K; Fukui H
Int J Oncol; 2001 Mar; 18(3):575-80. PubMed ID: 11179489
[TBL] [Abstract][Full Text] [Related]
6. Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression.
Cao H; Yang T; Li XF; Wu J; Duan C; Coates AL; Hu J
Gene Ther; 2011 Feb; 18(2):173-81. PubMed ID: 20882053
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated gene transfer into tumors: evaluation of direct readministration of an adenoviral vector into subcutaneous tumors of immunocompetent mice.
Nagao S; Kuriyama S; Okuda H; Tominaga K; Nakatani T; Tsujinoue H; Yoshiji H; Fukui H
Int J Oncol; 2001 Jan; 18(1):57-65. PubMed ID: 11115539
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of human sera on adenovirus-mediated gene transfer into rat liver.
Kuriyama S; Tominaga K; Kikukawa M; Nakatani T; Tsujinoue H; Yamazaki M; Nagao S; Toyokawa Y; Mitoro A; Fukui H
Anticancer Res; 1998; 18(4A):2345-51. PubMed ID: 9703877
[TBL] [Abstract][Full Text] [Related]
9. Repetitive and safe transgene expression in rat liver is achievable by adenoviral infusion into the common bile duct.
Kuriyama S; Yoshiji H; Tominaga K; Tsujinoue H; Nakatani T; Tsujimoto T; Okuda H; Akahane T; Deguchi A; Nakai S; Masaki T; Uchida N
Int J Mol Med; 2005 Oct; 16(4):503-8. PubMed ID: 16142379
[TBL] [Abstract][Full Text] [Related]
10. An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors.
Kuzmin AI; Galenko O; Eisensmith RC
Mol Ther; 2001 Mar; 3(3):293-301. PubMed ID: 11273770
[TBL] [Abstract][Full Text] [Related]
11. Suppression of the immune response to an adenovirus vector and enhancement of intratumoral transgene expression by low-dose etoposide.
Bouvet M; Fang B; Ekmekcioglu S; Ji L; Bucana CD; Hamada K; Grimm EA; Roth JA
Gene Ther; 1998 Feb; 5(2):189-95. PubMed ID: 9578838
[TBL] [Abstract][Full Text] [Related]
12. Immune responses to repetitive adenovirus-mediated gene transfer and restoration of gene expression by cyclophosphamide or etoposide.
Hamada K; Sakaue M; Sarkar A; Buchl S; Satterfield W; Keeling M; Sastry J; Roth JA; Follen M
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S177-86. PubMed ID: 16214207
[TBL] [Abstract][Full Text] [Related]
13. Neonatal cotton rats do not exhibit destructive immune responses to adenoviral vectors.
Zepeda M; Wilson JM
Gene Ther; 1996 Nov; 3(11):973-9. PubMed ID: 8940637
[TBL] [Abstract][Full Text] [Related]
14. Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.
Benihoud K; Esselin S; Descamps D; Jullienne B; Salone B; Bobé P; Bonardelle D; Connault E; Opolon P; Saggio I; Perricaudet M
Gene Ther; 2007 Mar; 14(6):533-44. PubMed ID: 17109009
[TBL] [Abstract][Full Text] [Related]
15. Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse.
Ye X; Robinson MB; Pabin C; Batshaw ML; Wilson JM
Gene Ther; 2000 Oct; 7(20):1761-7. PubMed ID: 11083498
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys.
Haegel-Kronenberger H; Haanstra K; Ziller-Remy C; Ortiz Buijsse AP; Vermeiren J; Stoeckel F; Van Gool SW; Ceuppens JL; Mehtali M; De Boer M; Jonker M; Boon L
Gene Ther; 2004 Feb; 11(3):241-52. PubMed ID: 14737083
[TBL] [Abstract][Full Text] [Related]
17. Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells.
Geutskens SB; van der Eb MM; Plomp AC; Jonges LE; Cramer SJ; Ensink NG; Kuppen PJ; Hoeben RC
Gene Ther; 2000 Aug; 7(16):1410-6. PubMed ID: 10981668
[TBL] [Abstract][Full Text] [Related]
18. Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: implications in gene therapy.
Moffatt S; Hays J; HogenEsch H; Mittal SK
Virology; 2000 Jun; 272(1):159-67. PubMed ID: 10873758
[TBL] [Abstract][Full Text] [Related]
19. Circumventing the immune response to adenovirus-mediated gene therapy.
Kass-Eisler A; Leinwand L; Gall J; Bloom B; Falck-Pedersen E
Gene Ther; 1996 Feb; 3(2):154-62. PubMed ID: 8867863
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of adenoviral transgene delivery via tail or portal vein into rat liver.
Herrmann J; Abriss B; van de Leur E; Weiskirchen S; Gressner AM; Weiskirchen R
Arch Virol; 2004 Aug; 149(8):1611-7. PubMed ID: 15290384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
